image description

Bailey W. Heaps

Partner

Bailey Heaps represents plaintiffs and defendants in high-stakes civil litigation. On the plaintiff side, he has represented biotech companies and former shareholders in milestone and royalty disputes and founders and executives in partnership and contract disagreements. He recently represented the former shareholders of FerroKin BioSciences against Shire Pharmaceuticals in a bench trial in the Delaware Court of Chancery, which awarded the firm’s clients more than $80 million, including the milestone payment due, attorney’s fees, and interest. That decision was affirmed by the Delaware Supreme Court. Mr. Heaps has also represented defendants large and small, in both state and federal court, in patent, false advertising, antitrust, and False Claims Act litigation. He maintains a robust pro bono practice, having represented a formerly incarcerated person with disabilities in a case about prison conditions and assisted with the firm’s challenge to the Trump Administration’s Muslim ban.

Prior to joining Keker, Van Nest & Peters, Mr. Heaps was a trial attorney in the Federal Programs Branch of the Civil Division of the U.S. Department of Justice, where he defended challenges to the legality of federal statutes and Executive Branch actions. Before joining the Justice Department, he clerked for the Honorable Judith W. Rogers on the D.C. Circuit and for the Honorable Keith P. Ellison on the federal district court in Houston.

Mr. Heaps graduated from Stanford Law School with pro bono distinction and graduated cum laude from Georgetown University with a B.A. in English and Government. During law school, Mr. Heaps participated in the Stanford Supreme Court Litigation Clinic, during which time he was a member of the team that represented Edith Windsor before the Supreme Court in her successful challenge to the Defense of Marriage Act. 

Bailey Heaps represents plaintiffs and defendants in high-stakes civil litigation. On the plaintiff side, he has represented biotech companies and former shareholders in milestone and royalty disputes and founders and executives in partnership and contract disagreements. He recently represented the former shareholders of FerroKin BioSciences against Shire Pharmaceuticals in a bench trial in the Delaware Court of Chancery, which awarded the firm’s clients more than $80 million, including the milestone payment due, attorney’s fees, and interest. That decision was affirmed by the Delaware Supreme Court. Mr. Heaps has also represented defendants large and small, in both state and federal court, in patent, false advertising, antitrust, and False Claims Act litigation. He maintains a robust pro bono practice, having represented a formerly incarcerated person with disabilities in a case about prison conditions and assisted with the firm’s challenge to the Trump Administration’s Muslim ban.

Prior to joining Keker, Van Nest & Peters, Mr. Heaps was a trial attorney in the Federal Programs Branch of the Civil Division of the U.S. Department of Justice, where he defended challenges to the legality of federal statutes and Executive Branch actions. Before joining the Justice Department, he clerked for the Honorable Judith W. Rogers on the D.C. Circuit and for the Honorable Keith P. Ellison on the federal district court in Houston.

Mr. Heaps graduated from Stanford Law School with pro bono distinction and graduated cum laude from Georgetown University with a B.A. in English and Government. During law school, Mr. Heaps participated in the Stanford Supreme Court Litigation Clinic, during which time he was a member of the team that represented Edith Windsor before the Supreme Court in her successful challenge to the Defense of Marriage Act. 

Keker, Van Nest & Peters Announces New Partners and Of Counsel

01/17/2023

Keker, Van Nest & Peters is pleased to announce that the firm has elevated associates Bailey Heaps, Katie Lynn Joyce, and Chris Sun to Partners, and Kristin Hucek and Ian Kanig to Of Counsel, effective January 1, 2023. Read more

Lance Armstrong Settles Federal Fraud Case for $5 Million

April 19, 2018

Lance Armstrong agreed on Thursday to pay $5 million to settle claims that he defrauded the federal government by using performance-enhancing drugs when the United States Postal Service sponsored his cycling team. Read more

Was it the Right Decision for Lance Armstrong to Settle his Lawsuit with the U.S. Government?

April 19, 2018

Five years after then-U.S. Attorney General Eric Holder announced that the U.S. Justice Department would co-sign onto Floyd Landis’s whistleblower lawsuit against Lance Armstrong, the sides have reached a settlement. Read more

  • The Most Adequate Branch: Courts as Competent Prison Reformers, 9 STAN. J. C.R. & C.L. 281 (2013).